--- title: "Brixadi vs. Other OUD Medications | CARMAhealth" description: "Brixadi vs. Other OUD Medications Brixadi is a new treatment option for people with opioid use disorder (OUD). It is an injectable form of buprenorphine…" canonical: https://carmahealth.com/blog/brixadi-vs-other-oud-medications source: https://carmahealth.com/blog/brixadi-vs-other-oud-medications mirror_of: carmahealth.com content_hash: sha256:4c18d62fe3052edbe9bc7e9666e190886a2e92cc7c65d28aa1677ed570bc4ddd generated_at: 2026-07-08T23:20:17.555Z robots: noindex, follow --- Blog # Brixadi vs. Other OUD Medications July 2, 2023 · CARMAhealth [All Articles](/blog) (image: Brixadi vs. Other OUD Medications) Brixadi is a new treatment option for people with opioid use disorder (OUD). It is an injectable form of buprenorphine, a medication that helps reduce cravings and withdrawal symptoms from opioids. Brixadi was approved by the FDA in May 2023 and is available in weekly and monthly doses. Brixadi is administered by a health care provider under the skin of the buttock, thigh, abdomen, or upper arm. Buprenorphine is one of the three FDA-approved medications for OUD, along with methadone and naltrexone. However, Brixadi has some advantages over other buprenorphine products and other treatments. Unlike methadone, which can only be dispensed at specialized clinics, Brixadi can be prescribed or administered by any health care provider who has completed some basic training in the treatment of OUD. This makes Brixadi more accessible and convenient for patients who may have difficulty traveling to a clinic or pharmacy. Unlike other buprenorphine products, such as tablets, films, or implants, Brixadi is available in weekly and monthly doses. This means that patients do not have to take medication every day or visit their provider as often. Brixadi also eliminates the risk of diversion, misuse, or accidental exposure of buprenorphine to children or pets. Unlike naltrexone, which is an opioid blocker that requires patients to be abstinent from opioids for about a week before starting treatment, Brixadi can be initiated after a single dose of a transmucosal buprenorphine product or in patients who are already on buprenorphine. This makes Brixadi easier to start and reduces the risk of relapse during induction. Brixadi needs to be part of a comprehensive treatment plan that includes counseling and psychosocial support. It can help people with OUD achieve and maintain long-term recovery. Reach out to your prescriber [at CARMAhealth](/contact-us/) to see if it is a potential option for you. #### CARMAHEALTH TESTIMONIAL > This place was great for me my life has changed an I feel great now. Thanks Carma! **Joey Castillo** > Dr. Powell is amazing, as well as the staff. I would highly recommend this place to anyone. **Kate Penshorn** > Excellent mental health professionals in Austin!!! They truly care about their patients by offering first-class services!! **David B. Hutts** #### OPENING HOURS
Week Days8:00 – 5:00
SaturdayClosed
SundayClosed
#### Austin: [512-212-4670](tel:512-212-4670) #### Florida: [754-800-6301](tel:754-800-6301) #### [OUR MISSION](#e36f6bc6ffc8e8283) CARMAhealth adopts a collaborative model of care that blends primary care medicine and behavioral health. We adopt a pragmatic, risk informed approach to care. Our goal is to create a medical home through the life span for our patients, their family and our community. **Sources and further reading: **[https://www.aafp.org/pubs/afp/issues/2019/1001/p416.html https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/buprenorphine https://www.fda.gov/news-events/press-announcements/fda-approves-new-buprenorphine-treatment-option-opioid-use-disorder](https://www.fda.gov/news-events/press-announcements/fda-approves-new-buprenorphine-treatment-option-opioid-use-disorder) ## Make An Appointment ### Contact our friendly and knowledgeable representatives to schedule your appointment and learn more about what we can do for you. [SCHEDULE APPOINTMENT](https://carmahealth.com/contact-us/) Keep Reading ## Related Articles [ (image: Ozempic: A Potential Anti-Addiction Drug?) July 25, 2023 ### Ozempic: A Potential Anti-Addiction Drug? Ozempic: A Potential Anti-Addiction Drug? Ozempic is a semaglutide medication originally developed to treat type 2 diabetes and obesity by… Learn more ](/blog/ozempic-a-potential-anti-addiction-drug)[ (image: Brixadi: A New Treatment Option for Opioid Use Disorder) July 2, 2023 ### Brixadi: A New Treatment Option for Opioid Use Disorder Brixadi: A New Treatment Option for Opioid Use Disorder Opioid use disorder (OUD) is a chronic and potentially fatal condition that affect… Learn more ](/blog/brixadi-a-new-treatment-option-for-opioid-use-disorder)[ (image: Understanding Meth Addiction: A Growing Threat) May 8, 2019 ### Understanding Meth Addiction: A Growing Threat Understanding Meth Addiction: A Growing Threat Rampant and escalating fatality has steered the American addiction conversation toward opio… Learn more ](/blog/understanding-meth-addiction-a-growing-threat) Take the First Step ## Start Feeling Like Yourself Again Whether you're exploring treatment for the first time or looking for a new practitioner, our psychiatrists are here to listen. [Book an Appointment](/new-patients) [Call (512) 212-4670](tel:5122124670) Accepting new patients · 15+ insurance plans accepted · Telehealth available